home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

105.29 -0.32 (-0.30%)

Streaming Delayed Price Updated: 12:03 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

57 58 Next >

Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High ↗

January 24, 2024

The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow...

Via Benzinga

Topics Stocks

Netflix, Tesla And 3 Stocks To Watch Heading Into Wednesday ↗

January 24, 2024

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗

January 23, 2024

Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.

Via Benzinga

7 Safe-Haven Stocks to Protect Your Portfolio During a Recession ↗

January 23, 2024

We may not be out of the woods yet, which means certain stable enterprises should be on your radar.

Via InvestorPlace

Earnings Preview For Abbott Laboratories ↗

January 23, 2024

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today ↗

January 19, 2024

Via Benzinga

$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

January 11, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 23, 2024

Via Benzinga

Johnson & Johnson's stock price is at a critical turning point

January 23, 2024

Johnson & Johnson's dividend is safe for 2024 and may include another increase for this Dividend King. Results suggest another solid quarter for medtech.

Via MarketBeat

Topics Intellectual Property

Top Stocks To Watch As Earnings Approach ↗

January 23, 2024

Several expansive companies are expected to post stellar quarterly growth when they report Q4 earnings on Wednesday, January 24. Here are a few top-rated stocks to consider as their quarterly results...

Via Talk Markets

My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024 ↗

January 21, 2024

These stocks may help you win in 2024 -- no matter what the market does.

Via The Motley Fool

Beyond The Numbers: 5 Analysts Discuss Abbott Laboratories Stock ↗

January 03, 2024

Via Benzinga

Could Abbott Laboratories Stock Help You Become a Millionaire? ↗

January 03, 2024

There is a lot going the company's way, despite recent struggles.

Via The Motley Fool

Where Abbott Laboratories Stands With Analysts ↗

December 13, 2023

Via Benzinga

S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday? ↗

January 22, 2024

US stocks rise to record highs on strong earnings reports, with small caps outperforming. Dollar steady, gold down, oil up. Bitcoin tumbles. AMD, TSLA, ADM, GILD, WDC top movers. GE, AAPL, FB, AMZN,...

Via Benzinga

Topics Stocks

Medtronic receives FDA approval for deep brain stimulation system

January 17, 2024

Medical device maker Medtronic PLC (NYSE: MDT) received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DBS)

Via MarketBeat

Tesla, Netflix, Intel Take Center Stage In Pivotal Q4 Earnings Week As S&P 500 Eyes Breaking New Highs ↗

January 22, 2024

According to Factset, the fourth-quarter earnings season has had a weak start, with the percentage of S&P 500 companies reporting positive earnings surprises below average.

Via Benzinga

Topics Stocks

Better Growth Stock: Abbott vs. AbbVie ↗

January 16, 2024

These healthcare giants also offer investors the promise of increasing passive income.

Via The Motley Fool

Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' ↗

January 12, 2024

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursda

Via Benzinga

3 Dividend Kings For Yield And Growth ↗

January 11, 2024

Dividend Kings are known for safe dividends and reliable long-term growth.

Via Talk Markets

2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade ↗

January 11, 2024

Strong advantages over the competition could allow these businesses to keep raising their dividend payouts for at least another 10 years.

Via The Motley Fool

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

January 08, 2024

From Tandem Diabetes Care, Inc.

Via Business Wire

3 Top Dividend Growth Stocks to Buy in 2024 ↗

January 02, 2024

Income investors should love these great stocks.

Via The Motley Fool

Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts ↗

December 28, 2023

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...

Via Benzinga

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population ↗

December 27, 2023

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Via InvestorPlace

Topics Economy

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

December 26, 2023

Via Benzinga

5 Top Stocks to Buy With Your End-of-the-Year Bonus ↗

December 23, 2023

Your bonus could become the gift that keeps on giving.

Via The Motley Fool

Better Growth Stock: AbbVie vs. Abbott Laboratories ↗

December 21, 2023

Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?

Via The Motley Fool

Dividend Income Update For November 2023 ↗

December 16, 2023

It’s dividend income update time. This is one of my favorite times of the month, as I get to review the previous month of passive income received from my dividend income portfolio.

Via Talk Markets

3 No-Brainer Healthcare Stocks to Buy Right Now ↗

December 15, 2023

These players have what it takes to boost your portfolio over time.

Via The Motley Fool

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

57 58 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com